Not applicableUnknownNCT03730675What this trial is testingIrradiation Stent Placement Plus TACE for HCC and PVTTWho this might be right forHepatocellular CarcinomaPortal Vein Tumor Thrombosis Zhongda Hospital 308
Not applicableStudy completedNCT00820157What this trial is testingCytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Eastern Hepatobiliary Surgery Hospital 120
Testing effectiveness (Phase 2)Study completedNCT05262959What this trial is testingA Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCCWho this might be right forDonafenib Shanghai Zhongshan Hospital 30
Not applicableUnknownNCT04523467What this trial is testingAnti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Eastern Hepatobiliary Surgery Hospital 320
Large-scale testing (Phase 3)Active Not RecruitingNCT04246177What this trial is testingSafety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)Who this might be right forCarcinoma, Hepatocellular Merck Sharp & Dohme LLC 480
Not applicableStudy completedNCT05332821What this trial is testingTACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCCWho this might be right forHepatocellular Carcinoma Zhongda Hospital 1,244
Large-scale testing (Phase 3)UnknownNCT02971345What this trial is testingEndovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor ThrombusWho this might be right forHepatocellular CarcinomaPortal Vein Tumor Thrombus Shanghai Zhongshan Hospital 253
Testing effectiveness (Phase 2)UnknownNCT02956772What this trial is testingTranscatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) PatientsWho this might be right forPrimary Hepatocellular Carcinoma Hunan Provincial People's Hospital 190
Testing effectiveness (Phase 2)Ended earlyNCT01381211What this trial is testingTransarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular Carcinoma University Hospital, Ghent 72
Large-scale testing (Phase 3)UnknownNCT05263219What this trial is testingDEB-TACE+HAIC vs. HAIC for Large HCCWho this might be right forUnresectable Hepatocellular Carcinoma Second Affiliated Hospital of Guangzhou Medical University 230
Early research (Phase 1)UnknownNCT03652467What this trial is testingThe Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Non-resectable Jinan Military General Hospital 100
Not applicableUnknownNCT05811481What this trial is testingRegorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted TherapyWho this might be right forHepatocellular CarcinomaTranscatheter Arterial ChEmoembolizationRegorafenib WenBo Guo 192
Testing effectiveness (Phase 2)Looking for participantsNCT07239245What this trial is testingStudy to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular CarcinamoWho this might be right forResectable Hepatocellular Carcinoma With High Risk of Recurrence Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Ended earlyNCT00576056What this trial is testingEffectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCCWho this might be right forCarcinoma, Hepatocellular University of Pittsburgh 19
Testing effectiveness (Phase 2)Study completedNCT04834674What this trial is testingDEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic CholangiocarcinomaTransarterial ChemoembolizationApatinib+1 more Sichuan Cancer Hospital and Research Institute 20
Not applicableStudy completedNCT02032368What this trial is testingDecrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma RecurrenceWho this might be right forCirculating Tumor Cell;Hepatocellular Carcinoma Guangdong Provincial People's Hospital 57
Testing effectiveness (Phase 2)Study completedNCT01853618What this trial is testingTremelimumab With Chemoembolization or Ablation for Liver CancerWho this might be right forHeptocellular CancerBiliary Tract NeoplasmsLiver Cancer+2 more National Cancer Institute (NCI) 61
Not applicableStudy completedNCT07449065What this trial is testingCECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCCWho this might be right forHepatocellular Carcinoma (HCC)Transarterial ChemoembolizationMicrovascular Invasion (MVI)+1 more First Affiliated Hospital, Sun Yat-Sen University 324
Testing effectiveness (Phase 2)Study completedNCT00826384What this trial is testingTransarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing PerfusionWho this might be right forHepatocellular Carcinoma Eastern Hepatobiliary Surgery Hospital 352
Large-scale testing (Phase 3)Study completedNCT00494299What this trial is testingPhase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)Who this might be right forCarcinoma, Hepatocellular Bayer 458